Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Helen Susan Kim

Director at Aktis Oncology, Inc. (AKTS)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-20.3%
vs. S&P 500-19.2%
Beat the market0%
Paper profit on buys+$125K
Total bought / sold$15.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jan 12SEC AKTSAktis Oncology, Inc. Buy 812,4555,671,825 held (+17%) $18.00 $14.6M +0.8%
Jan 12SEC AKTSAktis Oncology, Inc. Buy 22,545157,387 held (+17%) $18.00 $406K +0.8%
  • Buy

    Director Helen Susan Kim bought $14.6M of AKTS at $18.00 — first open-market purchase in our records.